Table B1.
| Mean practice performance rate (%) during the time period, including stratifications by practices that improved (+), did not change (0) or declined (−) in performance compared to the second pre-EHR time period (p2) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Measure | Second Pre-EHR (p2) Time Period | First Post-EHR (e1) Time Period | Second Post-EHR (e2) Time Period | |||||||||||||
| Total number of practices* | Overall Mean (SD) practice rate (%) | Stratified number of practices | Mean (SD) practice rate (%), stratified by e1 performance category | Stratified number of practices | Mean (SD) practice rate (%), stratified by e1 performance category | Stratified number of practices | Mean (SD) practice rate (%), stratified by e1 and e2 performance category | |||||||||
| Antithrombotic Therapy | (+) | 6 | 18.1 | (11.8) | (+) | 6 | 63.9 | (16.5) |
|
(+) | 6 | 69.4 | (11.2) | |||
|
(+) | 4 | 66.7 | (23.6) | ||||||||||||
| 24 | 25.63 | (17.3) | (0) | 17 | 25.4 | (14.6) | (0) | 17 | 41.9 | (16.4) | (0) | 13 | 48.1 | (18.0) | ||
| (−) | 1 | 75.5 | (N/A) | (−) | 1 | 42.9 | (N/A) |
|
(−) | 1 | 45.0 | (N/A) | ||||
| Blood Pressure Control | (+) | 3 | 34.7 | (30.0) | (+) | 3 | 62.0 | (17.8) |
|
(+) | 2 | 63.8 | (19.5) | |||
| (0) | 1 | 65.5 | (N/A) | |||||||||||||
|
|
(+) | 6 | 69.1 | (11.6) | ||||||||||||
| 27 | 48.33 | (15.4) | (0) | 20 | 47.1 | (11.0) | (0) | 20 | 47.7 | (10.9) | (0) | 14 | 53.2 | (7.5) | ||
|
(0) | 4 | 50.5 | (14.0) | ||||||||||||
| (−) | 4 | 64.6 | (12.1) | (−) | 4 | 28.2 | 12.8 | |||||||||
| Body Mass Index Recorded | (+) | 8 | 9.8 | (19.0) | (+) | 8 | 72.7 | (21.9) |
|
(+) | 8 | 85.3 | (13.4) | |||
|
|
(+) | 4 | 75.3 | (28.8) | ||||||||||||
| 31 | 64.97 | (42.0) | (0) | 10 | 71.9 | (39.7) | (0) | 10 | 74.6 | (34.0) | (0) | 6 | 97.3 | (2.5) | ||
|
(+) | 1 | 94.2 | (N/A) | ||||||||||||
| (0) | 4 | 85.5 | (6.6) | |||||||||||||
| (−) | 13 | 93.6 | (6.8) | (−) | 13 | 47.9 | (30.5) | (−) | 8 | 48.2 | (35.6) | |||||
| Cholesterol Testing |
|
(+) | 3 | 58.6 | (38.2) | |||||||||||
| 30 | 78.87 | (20.5) | (0) | 10 | 60.4 | (22.0) | (0) | 10 | 55.1 | (19.4) | (0) | 7 | 68.7 | (6.2) | ||
|
|
(+) | 1 | 68.4 | (N/A) | ||||||||||||
| (0) | 5 | 82.0 | (10.6) | |||||||||||||
| (−) | 20 | 88.1 | (12.0) | (−) | 20 | 41.9 | (22.9) | (−) | 14 | 54.8 | (24.0) | |||||
| Cholesterol Control | (+) | 2 | 64.3 | (2.6) | (+) | 2 | 86.3 | (2.9) |
|
(+) | 1 | 89.7 | (N/A) | |||
| (0) | 1 | 77.3 | (N/A) | |||||||||||||
| 26 | 80.32 | (8.6) | (0) | 22 | 81.3 | (7.7) | (0) | 22 | 83.9 | (6.9) |
|
(0) | 22 | 82.4 | (6.8) | |
|
|
(0) | 2 | 74.7 | (2.5) | ||||||||||||
| (−) | 2 | 85.4 | (2.3) | (−) | 2 | 64.6 | (3.0) | |||||||||
| Hemoglobin A1c Testing | (+) | 1 | 30.8 | (N/A) | (+) | 1 | 76.9 | (N/A) |
|
(+) | 1 | 80.0 | (N/A) | |||
| 23 | 67.43 | (17.7) | (0) | 13 | 62.9 | (14.8) | (0) | 13 | 53.8 | (17.0) |
|
(0) | 13 | 71.5 | (14.1) | |
|
|
(0) | 6 | 74.8 | (10.6) | ||||||||||||
| (−) | 9 | 78.0 | (14.2) | (−) | 9 | 31.1 | (19.8) | (−) | 3 | 42.4 | (27.2) | |||||
| Hemoglobin A1c Control | 4 | 45.21 | (15.0) | (0) | 4 | 45.2 | (15.0) | (0) | 4 | 43.3 | (15.8) |
|
(0) | 4 | 32.3 | (13.5) |
| Smoking Status Recorded | (+) | 16 | 40.9 | (33.3) | (+) | 16 | 86.8 | (13.6) |
|
(+) | 13 | 90.1 | (10.5) | |||
| (0) | 3 | 82.4 | (16.1) | |||||||||||||
|
|
(+) | 1 | 68.8 | (N/A) | ||||||||||||
| 31 | 62.27 | (34.5) | (0) | 7 | 83.6 | (20.0) | (0) | 7 | 85.1 | (14.8) | (0) | 6 | 93.0 | (9.0) | ||
|
|
(+) | 1 | 97.5 | (N/A) | ||||||||||||
| (0) | 1 | 96.5 | (N/A) | |||||||||||||
| (−) | 8 | 86.5 | (14.3) | (−) | 8 | 55.9 | (17.6) | (−) | 61.7 | (14.7) | ||||||
| Smoking Cessation Intervention | (+) | 1 | 15.4 | (N/A) | (+) | 1 | 89.5 | (N/A) |
|
(+) | 1 | 90.0 | (N/A) | |||
|
(+) | 1 | 81.8 | (N/A) | ||||||||||||
| 10 | 20.36 | (19.8) | (0) | 6 | 9.2 | (12.1) | (0) | 6 | 3.2 | (7.1) | (0) | 6.1 | (10.5) | |||
| (−) | 1 | 0.0 | (N/A) | |||||||||||||
|
|
(0) | 1 | 14.3 | (N/A) | ||||||||||||
| (−) | 3 | 44.4 | (12.2) | (−) | 3 | 1.5 | (2.5) | (−) | 2 | 0.0 | (0.0) | |||||
*
To be included in this analysis, practices needed to have a minimum of 10 patients qualifying for an individual measure in each of the three time periods
(+): practice performance significantly (p<0.05) improved compared to p2
(0): practice performance did not significantly change compared to p2
(−): practice performance significantly (p<0.05) declined compared to p2